 A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
 J ANTIINFECTIVES FOR SYSTEMIC USE
|
J01 ANTIBACTERIALS FOR SYSTEMIC USE
|
J02 ANTIMYCOTICS FOR SYSTEMIC USE
|
J04 ANTIMYCOBACTERIALS
|
J05 ANTIVIRALS FOR SYSTEMIC USE
|
J05A DIRECT ACTING ANTIVIRALS
|
J05AA Thiosemicarbazones
|
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
|
J05AB01 Aciclovir [DG:DG00406]
|
J05AB02 Idoxuridine
|
J05AB03 Vidarabine [DG:DG00645]
|
J05AB06 Ganciclovir [DG:DG00646]
|
J05AB09 Famciclovir
|
J05AB11 Valaciclovir [DG:DG00647]
|
 D08664 Valaciclovir (INN)
D00398 Valacyclovir hydrochloride (USP) <JP/US>
D10518 Valaciclovir hydrochloride hydrate (JAN) <JP/US>
|
J05AB12 Cidofovir [DG:DG00648]
|
J05AB13 Penciclovir [DG:DG00408]
|
J05AB14 Valganciclovir [DG:DG00649]
|
J05AB15 Brivudine
|
J05AB16 Remdesivir
|
J05AB17 Brincidofovir
|
J05AB18 Molnupiravir
|
J05AC Cyclic amines
|
J05AD Phosphonic acid derivatives
|
J05AE Protease inhibitors [DG:DG01647]
|
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
|
J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
|
J05AH Neuraminidase inhibitors [DG:DG02842]
|
J05AJ Integrase inhibitors [DG:DG03135]
|
J05AP Antivirals for treatment of HCV infections
|
J05AR Antivirals for treatment of HIV infections, combinations
|
J05AX Other antivirals
|
J06 IMMUNE SERA AND IMMUNOGLOBULINS
|
J07 VACCINES
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification